Cited by 142Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular and exercise physiology

The DOI matches its Crossref record; 108 of the 111 references it cites were found in a registry or an index.

Successes and failures of current treatment of heart failure

Cleland, John GF, Swedberg, Karl, Poole-Wilson, Philip A·1998·The Lancet

DOI 10.1016/s0140-6736(98)90015-0

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(98)90015-0

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
Swedberg, K. B., & KJEKSHUS, J. K. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Self-citation
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Ho, K. K. L., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D. A. (1993) · Circulation · doi:10.1161/01.cir.88.1.107 · Cited by 1,865
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · The Lancet · Cited by 1,860
Self-citation
A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Køber, L., Torp-Pedersen, C. T., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbæk, J., Cole, D. S., Auclert, L., Pauly, N., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332503 · Cited by 1,768
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
Pitt, B., Segal, R., Martínez, F. A., Meurers, G., Cowley, A. J., Thomas, I., DEEDWANIA, P. C., Ney, D. E., Snavely, D. B., & Chang, P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,660
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, Å. C., Swedberg, K. B., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,223
Self-citation
Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure
Packer, M., O’Connor, C. M., Ghali, J. K., Pressler, M. L., Carson, P. E., Belkin, R. N., Miller, A. B., Neuberg, G. W., Frid, D. J., WERTHEIMER, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351504 · Cited by 1,194
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
(1994) · Circulation · doi:10.1161/01.cir.90.4.1765 · Cited by 1,056
Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias after Coronary-Artery Bypass Graft Surgery
Bigger, J. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372201 · Cited by 1,010
Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective
Vasan, R. S., Benjamin, E. J., & Levy, D. A. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00381-9 · Cited by 882
Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
Packer, M., Gheorghiade, M., Young, J. B., Costantini, P. J., Adams, K. F., Cody, R. J., Smith, L. K., Voorhees, L. V., Gourley, L. A., & Jolly, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307013290101 · Cited by 830
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
Waagstein, F., Hjalmarson, Å. C., Varnauskas, E., & Wallentin, I. (1975) · Heart · doi:10.1136/hrt.37.10.1022 · Cited by 829
Readmission After Hospitalization for Congestive Heart Failure Among Medicare Beneficiaries
Krumholz, H. M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440220103013 · Cited by 821
Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
O'Mara, N. B., & Zimmerman, W. B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312093292417 · Cited by 639
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
Colucci, W. S., Packer, M., Bristow, M. R., Gilbert, E. M., Cohn, J. N., Fowler, M. B., Krueger, S. K., Hershberger, R. E., Uretsky, B. F., Bowers, J. A., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2800 · Cited by 628
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
McDonagh, T. A., Morrison, C., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J. J. V., & Dargie, H. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03033-x · Cited by 628
Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
- Australia/New Zealand Heart Failure Research Collaborative Group (20190096) (1997) · The Lancet · doi:10.1016/s0140-6736(97)80008-6 · Cited by 610
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
Packer, M., Colucci, W. S., Sackner‐Bernstein, J., Liang, C., Goldscher, D. A., Freeman, I., Kukin, M. L., Kinhal, V., Udelson, J. E., Klapholz, M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2793 · Cited by 605
Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction
Loh, E., Sutton, M. S. J., Wun, C., Rouleau, J. L., Flaker, G. C., Gottlieb, S. S., Lamas, G. A., Moyé, L. A., Goldhaber, S. Z., & Pfeffer, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360403 · Cited by 602
Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial
Uretsky, B. F., Young, J. B., Shahidi, F. E., Yellen, L., Harrison, M., & Jolly, M. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90403-n · Cited by 580
Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop)
Manolio, T. A., Baughman, K. L., Rodeheffer, R. R., Pearson, T. A., Bristow, J. D., Michels, V. V., Abelmann, W. H., & Harlan, W. R. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90901-a · Cited by 433
DOUBLE-BLIND COMPARISON OF CAPTOPRIL ALONE AGAINST FRUSEMIDE PLUS AMILORIDE IN MILD HEART FAILURE
Richardson, A., Scriven, A., Poole-Wilson, P. A., Bayliss, J., Parameshwar, J. K., & Sutton, G. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91074-9 · Cited by 432
Self-citation
PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE
Swedberg, K. B., Hjalmarson, Å. C., Waagstein, F., & Wallentin, I. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92010-5 · Cited by 418
Self-citation
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
Chadda, K., Goldstein, S., Byington, R. P., & Curb, J. D. (1986) · Circulation · doi:10.1161/01.cir.73.3.503 · Cited by 401
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
Kjekshus, J., Pedersen, T. R., Olsson, A. G., Færgeman, O., & Pyörälä, K. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90022-1 · Cited by 386
Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical Trials
Heidenreich, P. A., Lee, T. T., & Massie, B. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00104-6 · Cited by 357
Effect of the Calcium Antagonist Felodipine as Supplementary Vasodilator Therapy in Patients With Chronic Heart Failure Treated With Enalapril
Cohn, J. N., Ziesche, S., Smith, R. F., Anand, I. S., Dunkman, W. B., Loeb, H. S., Cintron, G. B., Boden, W. E., Baruch, L., Rochin, P., et al. (1997) · Circulation · doi:10.1161/01.cir.96.3.856 · Cited by 357
Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
Setaro, J. F., Zaret, B. L., Schulman, D. S., Black, H. R., & Soufer, R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90937-v · Cited by 349
Trends in hospitalization for heart failure in Scotland 1980-1990
McMurray, J. J. V., McDonagh, T., Morrison, C. E., & Dargie, H. J. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.9.1158 · Cited by 347
Ejection Fraction and Risk of Thromboembolic Events in Patients With Systolic Dysfunction and Sinus Rhythm: Evidence for Gender Differences in the Studies of Left Ventricular Dysfunction Trials
Dries, D. L., Rosenberg, Y., Waclawiw, M. A., & DOMANSKI, M. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00019-3 · Cited by 295
The treatment of heart failure
Remme, W. J., Cleland, J. G. F., Dargie, H. J., Erdmann, E., Ferrari, R., Kjekshus, J., Michel Komajda, N., Poole-Wilson, P. A., Riegger, G. A. J., Soler‐Soler, J., et al. (1997) · European Heart Journal · Cited by 293
Self-citation
Losartan in Heart Failure
Crozier, I., Ikram, H., Awan, N. A., Cleland, J. G. F., Stephen, N., Dickstein, K., Frey, M., Young, J. B., Klinger, G. H., Makris, L., et al. (1995) · Circulation · doi:10.1161/01.cir.91.3.691 · Cited by 288
Self-citation
The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report--1997.
Hosenpud, J. D., Bennett, L. E., Keck, B. M., Fiol, B., & Novick, R. J. (1997) · PubMed · Cited by 284
Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki, H., Kurihara, T., Yamaki, A., Inomata, N., Nozawa, Y., Mori, Y., Murasawa, S., Kizima, K., Maruyama, K., Horiuchi, M., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1885 · Cited by 260
EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTION
Snow, P. J. D. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90863-9 · Cited by 247
Guidelines for the diagnosis of heart failure
THE TASK FORCE ON HEART FAILURE OF THE EUROPEAN SOCIETY OF CARDIOLOGY (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060992 · Cited by 233
Effects of beta-blocker therapy on mortality in patients with heart failure: A systematic overview of randomized controlled trials
Doughty, R. N., Rodgers, A., Sharpe, N., & MacMahon, S. W. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015297 · Cited by 228
Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance
(1998) · European Heart Journal · doi:10.1053/euhj.1997.0736 · Cited by 208
Mode of death in chronic heart failure: A request and proposition for more accurate classification
Narang, R., Cleland, J. G. F., Erhardt, L., Ball, S., Coats, A. J. S., Cowley, A., Dargie, H. J., Hall, A. S., Hampton, J. R., & Poole-Wilson, A. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015074 · Cited by 203
Self-citation
Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure
Dickstein, K., Chang, P., Willenheimer, R. B., Haunsø, S., Remes, J., Hall, C., & KJEKSHUS, J. K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80020-h · Cited by 193
Coronary artery bypass grafting in patients with poor ventricular function
Christakis, G. T., Weisel, R. D., Fremes, S. E., Ivanov, J., David, T. E., Goldman, B. S., & Salerno, T. A. (1992) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)34872-x · Cited by 191
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison
Poole-Wilson, P. A. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0839 · Cited by 188
Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation.
Louie, H. W., Laks, H., Milgalter, E., Drinkwater, D. C., Hamilton, M. A., Rc, B., & Stevenson, L. W. (1991) · PubMed · Cited by 169
Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction
Rogers, W. J., Johnstone, D. E., Yusuf, S., Weiner, D. H., Gallagher, P. N., Bittner, V., Ahn, S. A., SCHRON, E. B., Shumaker, S. A., & Sheffield, L. T. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90426-x · Cited by 158
Prevalence, aetiology and management of heart failure in general practice.
Mair, F. S., Crowley, T. S., & Bundred, P. E. (1996) · PubMed Central · Cited by 156
Prevalence of heart failure in three general practices in north west London.
Parameshwar, J. K., Shackell, M. M., Richardson, A., Poole-Wilson, P. A., & Sutton, G. C. (1992) · PubMed · Cited by 146
Self-citation
Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993.
Reitsma, J. B., Mosterd, A., de Craen, A. J. M., Koster, R. W., van Capelle, F. J. L., Grobbee, D. E., & Tijssen, J. G. P. (1996) · Heart · doi:10.1136/hrt.76.5.388 · Cited by 138
Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995
Brown, A. M. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0859 · Cited by 134
Does Digoxin Provide Additional Hemodynamic and Autonomic Benefit at Higher Doses in Patients With Mild to Moderate Heart Failure and Normal Sinus Rhythm?
Slatton, M. L., Irani, W. N., HALL, S. A., Marcoux, L., Page, R. L., Grayburn, P. A., & Eichhorn, E. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00057-0 · Cited by 133
The Effect of Beta Adrenergic Blockade on Patterns of Urinary Sodium Excretion
Epstein, S. E., & D, E. B. M. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-65-1-20 · Cited by 126
Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals
Philbin, E. F., Andreou, C., Rocco, T. A., Lynch, L. J., & Baker, S. L. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89177-1 · Cited by 125
Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure
Giles, T. D., Katz, R. J., Sullivan, J. M., Wolfson, P., Haugland, M., Kirlin, P. C., Powers, E. R., Rich, S., Hackshaw, B. T., Chiaramida, A. J., et al. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90294-5 · Cited by 124
Withdrawal of long term diuretic medication in elderly patients: a double blind randomised trial
Walma, E., van Dooren, C., Prins, A., van der Does, E., & Hoes, A. W. (1997) · BMJ · doi:10.1136/bmj.315.7106.464 · Cited by 116
National Trends in the Initial Hospitalization for Heart Failure
Croft, J. B., Giles, W. H., Pollard, R. A., Casper, M. L., Anda, R. F., & Livengood, J. R. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00939.x · Cited by 114
Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.
Lang, R. M., Elkayam, U., Yellen, L. G., Krauss, D. J., McKelvie, R. S., Vaughan, D. E., Ney, D. E., Makris, L., & Chang, P. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00253-2 · Cited by 110
Beta-blocking agents in heart failure Should they be used and how?
Cleland, J. G. F., Bristow, M. R., Erdmann, E., Remme, W. J., Swedberg, K. B., & Waagstein, F. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014745 · Cited by 101
Self-citation
Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy
Grinstead, W. C., Francis, M. J., Marks, G. F., Tawa, C. B., Zoghbi, W. A., & Young, J. B. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90815-x · Cited by 96
What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
Narang, R., Swedberg, K. B., & Cleland, J. G. F. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014670 · Cited by 92
Self-citation
Cardiac Event Rates After Acute Myocardial Infarction in Patients Treated With Verapamil and Trandolapril Versus Trandolapril Alone
HANSEN, J. F., Hagerup, L. M., Sigurd, B. M., Pedersen, F., Mellemgaard, K., Pedersen-Bjergaard, O., & Mortensen, L. S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00860-0 · Cited by 91
Oral Torsemide in Patients With Chronic Congestive Heart Failure: Effects on Body Weight, Edema, and Electrolyte Excretion
Patterson, J. H., Adams, K. F., Applefeld, M. M., Corder, C. N., Mâsse, B. R., & The Torsemide Investigators Group (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02848.x · Cited by 88
Diltiazem Improves Cardiac Function and Exercise Capacity in Patients With Idiopathic Dilated Cardiomyopathy
Figulla, H. R., Gietzen, F. H., Zeymer, U., Raiber, M., Hegselmann, J., Soballa, R., & Hilgers, R. (1996) · Circulation · doi:10.1161/01.cir.94.3.346 · Cited by 86
SYMPTOMATIC ASSESSMENT OF PATIENTS WITH HEART FAILURE: DOUBLE-BLIND COMPARISON OF INCREASING DOSES OF DIURETICS AND CAPTOPRIL IN MODERATE HEART FAILURE
Cowley, A. J., Wynne, R. D., Stainer, K., Rowley, J. M., & Hampton, J. R. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90298-9 · Cited by 82
Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): Baseline characteristics, prognosis and response to therapy in the vasodilator in heart failure trials (V-HeFT)
Carson, P. E., Johnson, G. R., Fletcher, R. D., & Cohn, J. N. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00503-x · Cited by 81
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison The NETWORK investigators
Poole-Wilson, P. A. (1998) · Cited by 77
Self-citation
Effects of enalapril on long-term mortality in severe congestive heart failure
Kjekshus, J., Swedberg, K., & Snapinn, S. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90683-p · Cited by 76
Self-citation
Predicting survival after coronary revascularization for ischemic cardiomyopathy
Langenburg, S. E., Buchanan, S. A., Blackbourne, L. H., Scheri, R. P., Sinclair, K. N., Martinez, J., Spotnitz, W. D., Tribble, C. G., & Kron, I. L. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00755-a · Cited by 75
Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group.
Patterson, J. H., Adams, K. F., Applefeld, M. M., Corder, C. N., & Mâsse, B. R. (1994) · PubMed · Cited by 67
Anticoagulant and antiplatelet therapy in heart failure
Cleland, J. G. F. (1997) · Current Opinion in Cardiology · doi:10.1097/00001573-199705000-00009 · Cited by 67
Self-citation
Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement
Loebe, M. M., HENNIG, E., Müller, J. W., Spiegelsberger, S., Weng, Y., & Hetzer, R. (1997) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(97)01185-8 · Cited by 67
Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
Tsuyuki, R. T., Yusuf, S., Rouleau, J. L., Maggioni, A. P., McKelvie, R. S., Wiecek, E. M., Wang, Y., Pogue, J., Teo, K. K., White, M., et al. (1997) · PubMed · Cited by 63
Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure
Pacher, R., Stanek, B., Globits, S., Berger, R., Hülsmann, M., Frey, B., Schuller, M., Hartter, E., & Ogris, E. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015040 · Cited by 63
The role of calcium antagonists in the treatment of chronic heart failure
Parameshwar, J. K., & Poole-Wilson, P. A. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.suppl_a.38 · Cited by 47
Self-citation
Renal response to candoxatrilat in patients with heart failure
Good, J. M., Peters, A. M., Wilkins, M. R., Jackson, N. C., Oakley, C. M., & Cleland, J. G. F. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00561-4 · Cited by 44
Self-citation
Quality of life on treatment with Metoprolol in Dilated Cardiomyopathy: Results from the MDC trial
Wiklund, I. E., Waagstein, F., Swedberg, K. B., & Hjalmarsson, Å. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf02627961 · Cited by 43
Self-citation
Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
GUNDERSEN, T. (1983) · Heart · doi:10.1136/hrt.50.2.135 · Cited by 36
Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure study
Pouleur, H. G., Rousseau, M. F., Oakley, C. M., & Rydén, L. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90713-u · Cited by 34
ACE inhibitors for myocardial infarction: how should they be used?
Cleland, J. G. F. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060879 · Cited by 33
Self-citation
Successful mechanical circulatory support for more than two years with a left ventricular assist device in a patient with dilated cardiomyopathy.
Loebe, M. M., Weng, Y., Müller, J., Dandel, M., Halfmann, R., Spiegelsberger, S., & Hetzer, R. (1997) · PubMed · Cited by 33
Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction
Rousseau, M., MELIN, J., BENEDICT, C. R., AHN, S., Raphaël, D. A., Bornemann, M., & Pouleur, H. G. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060616 · Cited by 32
ACE inhibitors for the prevention and treatment of heart failure: why are they 'under-used'?
Cleland, J. G. F. (1995) · PubMed · Cited by 31
Self-citation
Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial.
Magnani, B., & Magelli, C. (1986) · PubMed · Cited by 30
Design of the cardiac insufficiency bisoprolol study II (OBIS II)
The CIBIS II Scientific Committee (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00181.x · Cited by 30
Changing patterns of investigation and treatment of cardiac failure in hospital.
Hillis, G. S., Al‐Mohammad, A., Wood, M., & Jennings, K. (1996) · Heart · doi:10.1136/hrt.76.5.427 · Cited by 29
Severity of heart failure and dosage of angiotensin converting enzyme inhibitors
Clark, A. L., & Coats, A. J. S. (1995) · BMJ · doi:10.1136/bmj.310.6985.973 · Cited by 28
Patient Characteristics in Cases of Chronic Severe Heart Failure with Different Degrees of Left Ventricular Systolic Dysfunction
Eriksson, S. V., KJEKSHUS, J. K., Offstad, J. T., & Swedberg, K. B. (2008) · Cardiology · doi:10.1159/000176668 · Cited by 27
Self-citation
Screening For Left Ventricular Dysfunction and Chronic Heart Failure
Cleland, J. G. F. (1997) · Disease Management & Health Outcomes · doi:10.2165/00115677-199701040-00001 · Cited by 24
Self-citation
Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction.
Herlitz, J. D., Hjalmarson, Å. C., Holmberg, S., Swedberg, K. B., VEDIN, A., Waagstein, F., Waldenström, A. P., Wedel, H., Wilhelmsen, L., & Wilhelmsson, C. (1984) · Heart · doi:10.1136/hrt.51.5.539 · Cited by 22
Self-citation
Measurement of the quality of life in congestive heart failure—Influence of drug therapy
Bulpitt, C. J., & FLETCHER, A. E. (1988) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00633423 · Cited by 21
How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?
Cleland, J. G. F., & Puri, S. (1994) · Heart · doi:10.1136/hrt.72.3_suppl.s81 · Cited by 21
Self-citation
A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure
Andrews, R. V., Charlesworth, A., Evans, A. J., & Cowley, A. J. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015351 · Cited by 16
Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study
Schofer, J., HOBUSS, M., Aschenberg, W., & Tews, A.-M. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059786 · Cited by 14
Angiography and the aetiology of heart failure
Brookes, C. I. O., Hart, P., Keogh, B. E., & Cleland, J. G. F. (1995) · Postgraduate Medical Journal · doi:10.1136/pgmj.71.838.480 · Cited by 12
Self-citation
Amlodipine in Chronic Heart Failure
Bobbio, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361413 · Cited by 8
Prognosis of heart failure — a population-based study of the outcome in incident cases
Cowie, M., Suresh, V., Wood, D. A., Coats, A. J. S., Thompson, S. G., Poole-Wilson, P. A., & Sutton, G. C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)81587-8 · Cited by 7
Self-citation
Influence of Aetiology on the Effects of Treatment in Heart Failure
Cleland, J. G. F., & Swedberg, K. B. (1999) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748739900600302 · Cited by 6
Self-citation
Prognosis of Heart Failure - A Population-based Study of the Outcome in Incident Cases
Cowie, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)84653-0 · Cited by 5
Dofetilide: A New Class III Antiarrhythmic Drug Which Is Safe in Patients With Congestive Heart Failure
Torp-Pedersen, C. T. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)84407-5 · Cited by 3
High- versus low-dose ACE-inhibition in patients with chronic heart failure: A placebo-controlled study with imidapril
vanVeldhuisen, D., GenthZoth, S., Netzer, T., & Brouwer, J. (1997) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1

Research works printed but not linked: 15

Remme, 1997, European Society of Cardiology: guidelines for the management of heart failure, Eur Heart J, 18, 736
Cleland, 1998, Health economic and quality of life issues in heart failure, Eur Heart J
Sherman, 1995, Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure: an epidemiologic perspective, J Am Coll Cardiol, 26, 1565
Lewis, 1991, Double-blind comparison of high-dose bumetanide and half-dose bumetanide together with captopril in heart failure, Curr Ther Res Clin Exp, 50, 3
Murray, 1998, Decreased hospitalisation for CHF by using a completely and predictably absorbed loop diuretic, J Am Coll Cardiol, 31, 465C
Abraham, 1997, Effects of an oral, nonpeptide, selective V2 receptor vasopressin antagonist in patients with chronic heart failure, J Am Coll Cardiol, 29, 169A
Gheorghiade, 1995, The effects of digoxin withdrawal in patients with stable heart failure due to coronary artery disease compared to primary cardiomyopathy; insights from the PROVED and RADIANCE studies, Circulation, 92, I, 142
Fowler, 1997, Comparison of high versus low-dose enalapril therapy on clinical outcomes and neuroendocrine activation in advanced heart failure, Circulation, 96, I, 20
Klinger, 1997, Effects of losartan on exercise capacity, morbidity and mortality in patients with symptomatic heart failure, JACC, 29, 205A
Herlitz, 1996, Effect of metoprolol among patients with suspected acute myocardial infarction and left ventricular dysfunction, Eur Heart J, 17, 514
Louie, 1991, 84, 290
1997, 337, 1576
Pedersen, 1997, Trandolapril reduces the incidence of atrial fibrillation following acute myocardial infarction, Circulation, 96, I, 75
Deedwania, 1996, Amiodarone improves survival by restoring and maintaining sinus rhythm in patients with chronic atrial fibrillation, dialted cardiomyopathy, and congestie heart failure, Circulation, 94, I, 663
Kjekshus, 1997, The effects of simvastatin on the incidence of heart failure patients with coronary heart disease, J Card Fail, 3, 249, 10.1016/S1071-9164(97)90022-1 · DOI · Paper page

Sorted by citations

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C. M., Garrigue, S., KAPPENBERGER, L. J., Haywood, G. A., Santini, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441202 · Cited by 2,718
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
Troughton, R. W., FRAMPTON, C. M. A., Yandle, T. G., Espine, E. A., Nicholls, M. G., & Richards, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02060-2 · Cited by 1,358
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca 2+ -ATPase in Patients With Advanced Heart Failure
Jessup, M., Greenberg, B., Mancini, D., Cappola, T., Pauly, D. F., Jaski, B., Yaroshinsky, A., Zsebo, K. M., Dittrich, H., & Hajjar, R. J. (2011) · Circulation · doi:10.1161/circulationaha.111.022889 · Cited by 760
Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block
Nelson, G. S., Berger, R. D., Fetics, B. J., Talbot, M. W., Spinelli, J., Hare, J. M., & Kass, D. A. (2000) · Circulation · doi:10.1161/01.cir.102.25.3053 · Cited by 759

See all 142

Authors: Cleland, J. G., Swedberg, K., & Poole-Wilson, P. A.
Affiliations: University of Glasgow (GB)
Imperial College London (GB)
Corresponding author: Cleland, John GF
ORCID: Cleland, John GF
Swedberg, Karl
Venue: The Lancet
Publisher: Elsevier BV
Published: 1998-08
Volume: 352
Pages: SI19-SI28
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(98)90015-0
OpenAlex: W2075926626
Cited by: 141
References: 111
Citations by year: 2026: 1 · 2025: 2 · 2022: 3 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 3 · 2014: 1 · 2013: 5 · 2012: 2
FWCI: 3.10
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
Keywords: heart failure, heart failure treatment, exercise capacity, hemodynamics, symptom improvement, surrogate endpoints, clinical trial endpoints, drug approval
MeSH terms: Cardiac Output, Low, Clinical Trials as Topic, Humans, Prognosis, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Successes and failures of current treatment of heart failure

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks